Acceleron Pharma logo

Acceleron Pharma

Accelerating drug discovery to transform patients' lives

67 employees · est. 2003 · Cambridge, United States

VS
ImmuneCyte, Inc. logo

ImmuneCyte, Inc.

A HealthBanks Biotech Company

51-200 employees · est. 2015 · Irvine, United States

Acceleron Pharma is the older company (2003 vs 2015).

Side-by-Side Comparison

Acceleron Pharma ImmuneCyte, Inc.
Founded
2003 older 2015
Headquarters
Cambridge, United States Irvine, United States
Employees
67 51-200
Industry
Biotechnology, Health Care, Manufacturing Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Post Ipo Equity Not tracked yet
Total Funding
Not tracked yet Not tracked yet
Funding Rounds
15 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, Musculoskeletal Diseases, Cancer Therapeutics, Metabolic Disorders, Muscle Loss Therapies, Neuromuscular Diseases, Angiogenesis Therapies, Drug Discovery, Biotherapeutics, Cellular Proliferation, Differentiation Factors, Tissue Regeneration, Clinical Research Biopharmaceutical, Cell Therapies, Gene Therapeutics, CAR-T Cell, CAR-NK Cell, Mononuclear Cell Therapies, Cancer Treatment, Vascular Diseases, Immunotherapy, COVID-19, Multilingual, Orthopaedic Diseases, Age-related Illnesses, B-thalassemia, Gene Treatments
Website
acceleronpharma.com immunecyte.com
Acceleron Pharma logo

About Acceleron Pharma

Acceleron Pharma is a biotechnology company founded in 2003 with a clear vision encapsulated in their slogan, "Accelerating drug discovery to transform patients' lives." On November 22, 2021, the company underwent a significant change as it became a wholly-owned subsidiary of Merck & Co., Inc. This...

ImmuneCyte, Inc. logo

About ImmuneCyte, Inc.

ImmuneCyte, Inc., a subsidiary of HealthBanks Biotech, is a pioneering player in the biotechnology industry, focused on advancing cutting-edge cell and gene therapeutics for cancer and vascular diseases. The company, founded in 2015, is at the forefront of developing revolutionary therapies such as...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Acceleron Pharma and ImmuneCyte, Inc. — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Acceleron Pharma and ImmuneCyte, Inc. — by email.

Frequently Asked Questions

Acceleron Pharma — Accelerating drug discovery to transform patients' lives. ImmuneCyte, Inc. — A HealthBanks Biotech Company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Acceleron Pharma and ImmuneCyte, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Acceleron Pharma with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy